13F
中

ORMP ORAMED PHARMACEUTICALS INC

2026Q1 · CUSIP 68403P203 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
63
Δ holders QoQ
+6
Breadth percentile
Top 39%
Whale holders
33
Δ whales
+5
Inst. holding value
$45M
New positions
16
Closed positions
10
Price momentum (1Q)
—
Put / Call
0/0

Breadth history (34 quarters)

2018Q1: Δ-6 · h=21 2018Q2: Δ+0 · h=21 2018Q3: Δ+8 · h=29 2018Q4: Δ+0 · h=29 2019Q1: Δ-3 · h=26 2019Q2: Δ+1 · h=27 2019Q3: Δ+5 · h=32 2019Q4: Δ+0 · h=32 2020Q1: Δ-1 · h=31 2020Q2: Δ+5 · h=36 2020Q3: Δ+0 · h=36 2020Q4: Δ+3 · h=39 2021Q1: Δ+7 · h=46 2021Q2: Δ+31 · h=77 2021Q3: Δ+15 · h=92 2021Q4: Δ+23 · h=115 2022Q1: Δ-13 · h=102 2022Q2: Δ-13 · h=89 2022Q3: Δ-18 · h=71 2022Q4: Δ+6 · h=77 2023Q1: Δ-15 · h=62 2023Q2: Δ-12 · h=50 2023Q3: Δ+6 · h=56 2023Q4: Δ+0 · h=56 2024Q1: Δ-5 · h=51 2024Q2: Δ+8 · h=59 2024Q3: Δ-4 · h=55 2024Q4: Δ+2 · h=57 2025Q1: Δ-4 · h=53 2025Q2: Δ-5 · h=48 2025Q3: Δ-1 · h=47 2025Q4: Δ+10 · h=57 2026Q1: Δ+6 · h=63 2018Q1: holders=21 2018Q2: holders=21 2018Q3: holders=29 2018Q4: holders=29 2019Q1: holders=26 2019Q2: holders=27 2019Q3: holders=32 2019Q4: holders=32 2020Q1: holders=31 2020Q2: holders=36 2020Q3: holders=36 2020Q4: holders=39 2021Q1: holders=46 2021Q2: holders=77 2021Q3: holders=92 2021Q4: holders=115 2022Q1: holders=102 2022Q2: holders=89 2022Q3: holders=71 2022Q4: holders=77 2023Q1: holders=62 2023Q2: holders=50 2023Q3: holders=56 2023Q4: holders=56 2024Q1: holders=51 2024Q2: holders=59 2024Q3: holders=55 2024Q4: holders=57 2025Q1: holders=53 2025Q2: holders=48 2025Q3: holders=47 2025Q4: holders=57 2026Q1: holders=63 -31 -15.5 +0 +15.5 +31 1870121 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 2 lit events

Period Percentile Next-1Q return Next-2Q return
2021Q3 Top 12% -58.5% -83.9%
2021Q2 Top 7% — —

Options Sentiment

Put holders
0
QoQ: 0
Call holders
0
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
1.6
EPS (TTM)
$2.60
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Quarterly Revenue & EPS (4Y)
2022-06-30: EPS 0.27 2022-09-30: EPS 0.18 2022-12-31: EPS -1.66 2023-03-31: EPS -0.08 2023-06-30: EPS -0.03 2023-09-30: EPS -0.08 2023-12-31: EPS 0.33 2024-03-31: EPS 0.04 2024-06-30: EPS 0.22 2024-09-30: EPS -0.48 2024-12-31: EPS -0.26 2025-03-31: EPS -0.19 2025-06-30: EPS 0.31 2025-09-30: EPS 1.13 2025-12-31: EPS 0.25 2026-03-31: EPS 0.91 -1.83 -0.29 1.24 20222023202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 4 2023-12-31: PE 20.92024-03-31: PE 8.22024-06-30: PE 4.32024-09-30: PE 18.92025-09-30: PE 2.22025-12-31: PE 2.22026-03-31: PE 1.8 2 12 22 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)